Skip to main content
×
×
Home

Depot antipsychotics revisited

  • David Taylor (a1)
Extract

Many typical antipsychotic drugs may be manufactured as alcohols, which react with carboxylic acids to form esters (organic salts). These compounds are highly oil-soluble, but are only sparingly soluble in aqueous fluids such as blood. Thus, an oily solution of an antipsychotic can be injected into a muscle, where it forms a reservoir or ‘depot’ of drug that is slowly dissolved in the surrounding blood. Once released into the blood, drug esters are rapidly hydrolysed by endogenous esterase enzymes to produce the parent antipsychotic. Stable serum concentrations of antipsychotics are usually engendered (although this is not always observed in practice (Tuninger & Levander, 1996)), and administration need only take place every few weeks or so. Adherence can be assured and relapse rates are reduced (Groves & Mandel, 1975: Davis et al, 1994).

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Depot antipsychotics revisited
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Depot antipsychotics revisited
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Depot antipsychotics revisited
      Available formats
      ×
Copyright
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
Hide All
Amdisen, A., Aaes-Joergensen, T., Thomsen, N. J., et al (1986) Serum concentrations and clinical effect of zuclopenthixol in acutely disturbed, psychotic patients treated with zuclopenthixol acetate in ‘Viscoleo’®. Psychopharmacology, 90, 412 416.
Association of British Pharmaceutical Industry (1996) Compendium of Data Sheets and Summaries of Product Characteristics 1996/97. London: Datapharm Publications.
Ayd, F. J. Jr (1975) The depot fluphenazines: a reappraisal after 10 years' clinical experience. American Journal of Psychiatry, 132, 491 500.
Beresford, R. & Ward, A. (1987) Haloperidol decanoate: a preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in psychosis. Drugs 33, 31 49.
Carney, M. W. P. & Sheffield, B. F. (1976) Comparison of antipsychotic depot injections in the maintenance treatment of schizophrenia. British Journal of Psychiatry, 128, 476 481.
Chakravarti, S. K., Muthu, A., Muthu, P. K., et al (1990) Zuclopenthixol acetate (5% in ‘Viscoleo’): single-dose treatment for acutely disturbed psychotic patients. Current Medical Research and Opinion, 12, 58 65.
Coutinho, E., Fenton, M., Campbell, C., et al (1997). Details of studies of zuclopenthixol acetate are needed. British Medical Journal 315, 884.
Currey, S. H., Whelpton, R., de Schepper, P. J., et al (1979) Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man. British Journal of Clinical Pharmacology, 7, 325 331.
Davis, J. M., Matalon, L., Watanabe, M. D., et al (1994) Depot antipsychotic drugs: place in therapy. Drugs, 47, 741 773.
Dom, R., De Mesmaecker, M., van den Broucke, T., et al (1978) Maintenance treatment of chronic schizophrenic patients: a study with the long-acting thioxanthene derivative, cis(Z)-clopenthixol decanoate–sordinol® depot. Acta Psychiatrica Scandinavica, 57, 299 304.
Ereshefsky, L., Saklad, S. R., Jann, M. W., et al (1984) Future of depot neuroleptic therapy: pharmacokinetic and pharmacodynamic approaches. Journal of Clinical Psychiatry, 45, 50.
Girard, M., Granier, F., Schmitt, L., et al (1984) Initial results of a pharmacokinetic study of pipothiazine and its palmitic ester. (Piportil L4) in a schizophrenic population. Encéphale, 10, 171 176.
Groves, J. E. & Mandel, M. R. (1975) The long-acting phenothiazines. Archives of General Psychiatry, 32, 893 900.
Hay, J. (1995) Complications at site of injection of depot neuroleptics. British Medical Journal, 311, 421.
Jørgensen, A. (1978) Pharmacokinetic studies on flupenthixol decanoate, a depot neuroleptic of the thioxanthene group. Drug Metabolism Reviews, 8, 235 249.
Marr, W. & Batchelor, D. (1982) Haloperidol decanoate: major progress with antipsychotic therapy. Clinical Research Reviews, 2, 61 79.
Nyberg, S., Farde, L., Halldin, C., et al (1995) D2 dopamine receptor occupancy during low-dose treatment with haloperidol decanoate. American Journal of Psychiatry, 152, 173 178.
Reynolds, J. E. F. (1996) Martindale – The Extra Pharmacopoeia (31st edn). London: Royal Pharmaceutical Society of Great Britain.
Reyntjens, A. J. M., Heykants, J. J. P., Woestenborghs, R. J. H., et al (1982) Pharmacokinetics of haloperidol decanoate: a two-year follow-up. International Pharmacopsychiatry, 17, 238 246.
Taylor, D. (1997) Switching from typical to atypical antipsychotics: practical guidelines. CNS Drugs, 8, 285 292.
Tuninger, E. & Levander, S. (1996) Large variations of plasma levels during maintenance treatment with depot neuroleptics. British Journal of Psychiatry, 168, 618 621.
Van Praag, H. M. & Dols, L. C. W. (1973) Fluphenazine enanthate and fluphenazine decanoate: a comparison of their duration of action and motor side effects. American Journal of Psychiatry, 130, 801 804.
Warner, A. M. & Wyman, S. M. (1975) Delayed severe extrapyramidal disturbance following frequent depot phenothiazine administration. American Journal of Psychiatry, 132, 743 745.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Bulletin
  • ISSN: 0955-6036
  • EISSN: 1472-1473
  • URL: /core/journals/bjpsych-bulletin
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 1 *
Loading metrics...

Abstract views

Total abstract views: 7 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 18th July 2018. This data will be updated every 24 hours.

Depot antipsychotics revisited

  • David Taylor (a1)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *